In addition, miR‐621 was found to inhibit the malignant progression of non‐small cell lung cancer (NSCLC) by targeting SIX4, indicating that SIX4 functions as an oncogene in NSCLC.10 The gene discussed is SIX4; the disease is non-small cell lung carcinoma.